5:17 PM
 | 
Mar 24, 2014
 |  BC Extra  |  Company News

FDA committee to discuss QRxPharma's MoxDuo IR

FDA's Anesthetic and Analgesic Drug Products Advisory Committee will meet on April 22 to discuss a resubmitted NDA from QRxPharma Ltd. (ASX:QRX; OTCQX:QRXPY)...

Read the full 97 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >